CSE/KETA (CSE/KETA)

Canadian Securities Exchange: CSE/KETA · CAD

CA$0.19

+0.05 (+35.7%)· Recorded snapshot

Market cap	1.3M
Shares out	6.7M
Volume	500
Beta	0.27

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Market cap: 1.3M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 11P50 16.8P75 23.9

Trailing P/En/a

P25 9.9P50 23.3P75 38.5

ROEn/a

P25 -104.1P50 -30P75 6.7

ROICn/a

P25 -55.9P50 -12.1P75 5

Benchmarks · 1M

S&P 500-0.5%

Nasdaq Composite-4.9%

Dow Jones Industrial Average+2.2%

Russell 2000+1.2%

All CSE/KETA indicators

Market & fundamental data

Available fields

Groups with data

Currency

CAD

Showing 86 of 86 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Exchange	Canadian Securities Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Health Information Services
Is primary listing	Yes
ISIN number	CA89680B2049
Last refreshed	2026-10-29
Last stock split date	2023-08-30
Last stock split type	Reverse
Market cap	CAD 1.3M
Price	CAD 0.19
Price currency	CAD
Sector	Healthcare
SIC code	7372
Stock price date	2026-06-08
Symbol	cse/KETA
Website	https://www.tripsitter.clinic

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	2
EPS growth years	3
Net income growth quarters	2
Net income growth years	3
Revenue growth years	0

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
WACC	5.73%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CAD 0.14
1D price change	35.71%
1M price change	35.71%
1M total return	35.71%
1W price change	18.75%
1W total return	18.75%
1Y price change	100%
1Y return CAGR	100.1%
1Y total return	100%
20-day SMA	CAD 0.13
200-day SMA	CAD 0.30
3M price change	192.31%
3M total return	192.31%
3Y price change	26.67%
3Y return CAGR	8.2%
3Y total return	26.67%
50-day SMA	CAD 0.10
50-day SMA vs 200-day SMA	50under200
52-week high	CAD 0.25
52-week high date	2026-02-06
52-week low	CAD 0.06
52-week low date	2026-02-13
6M price change	245.46%
6M total return	245.46%
All-time high	CAD 6.75
All-time high date	2021-11-29
All-time low	CAD 0.02
All-time low date	2024-02-08
Average true range (ATR)	CAD 0.02
Average volume	17.1K
Beta (1Y)	-29.13
Beta (2Y)	-14.02
Beta (5Y)	0.27
Change from 52-week high	-24%
Change from 52-week low	245.46%
Change from all-time high	-97.19%
Change from all-time low	1,166.67%
Change from open	0%
Day's gap	35.71%
Dollar volume	CAD 95
High price	CAD 0.19
Low price	CAD 0.19
Monthly RSI	26.43
Open price	CAD 0.19
Previous close	CAD 0.14
Price vs 150-day SMA	36.01%
Price vs 20-day SMA	41.47%
Price vs 200-day SMA	-35.83%
Price vs 50-day SMA	89.24%
Relative volume	0.03
RSI	60.46
Sharpe ratio	1.35
Sortino ratio	3.11
Volume	500
Weekly RSI	45.73
YTD price change	245.46%
YTD total return	245.46%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.5M
Shares held by insiders	38.19%
Shares outstanding	6.7M

Deeper analysis on CSE/KETA

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this CSE/KETA report

Is a complete CSE/KETA research report available?

No complete published report is available for cse/KETA (CSE/KETA) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.